Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2012
04/05/2012WO2011121418A9 4 - aminopyrimidine derivatives and their as as adenosine a2a receptor antagonists
04/05/2012US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083489 Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonists
04/05/2012US20120083488 Tetracyclic compound
04/05/2012US20120083475 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
04/05/2012US20120083474 Heterocyclic amides as modulators of trpa1
04/05/2012US20120083004 Diagnostic Method for Celiac Sprue
04/05/2012US20120082702 Nicotinamide compounds useful as kinase modulators
04/05/2012US20120080585 Photoelectric conversion element, production method thereof, photosensor, imaging device and their driving method
04/05/2012CA2812935A1 Novel piperazine analogs with substituted heteroaryl groups as broad-spectrum influenza antivirals
04/05/2012CA2811192A1 1,2,4-triazolone derivative
04/04/2012EP2437326A2 Organic electroluminescent element, display device and lighting device
04/04/2012EP2436683A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
04/04/2012EP2436676A1 Human adam-10 inhibitors
04/04/2012EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
04/04/2012EP2435430A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
04/04/2012EP2435429A1 Hepatitis c virus inhibitors
04/04/2012EP2435428A1 Substituted piperidines
04/04/2012EP2435427A1 Substituted piperidines
04/04/2012EP2435426A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
04/04/2012EP2435422A1 Pyrimidine inhibitors of kinase activity
04/04/2012EP2435051A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
04/04/2012EP2435048A1 Radiolabeled pde10 inhibitors
04/04/2012EP2193112B1 Electroluminescent device
04/04/2012EP2021327B1 Antidiabetic bicyclic compounds
04/04/2012EP1615878B1 Compounds, compositions and methods of treatment for heart failure
04/04/2012EP1565452B1 3-substituted-6-aryl pyridines as ligands of c5a receptors
04/04/2012CN1950347B 作为酪氨酸激酶抑制剂的2-氨基芳基噁唑化合物 As the tyrosine kinase inhibitors 2-aryl-oxazole compounds
04/04/2012CN1930143B 具有微粒体甘油三酸酯传递蛋白质抑制活性的被五元杂环取代的芳基哌啶或哌嗪 Having microsomal triglyceride transfer protein inhibiting activity by five-membered heterocyclic aryl substituted piperidine or piperazine
04/04/2012CN102405211A Proline derivatives as cathepsin inhibitors
04/04/2012CN102399215A Indole alkaloids (phidianidine A and phidianidine B) and preparation method and application thereof
04/04/2012CN102399214A 2-(2-取代-1,3,4-噁二唑-5-基)-苯并异硒唑酮衍生物的制备方法 2- (2-substituted-1,3,4-oxadiazol-5-yl) - Preparation benzisoselenazol-ketone derivative
04/04/2012CN101759692B 硫代羰基化合物及其药物用途 Thiocarbonyl compounds and pharmaceutical use
04/04/2012CN101217957B 2,3 substituted pyrazine sulfonamides as inhibitors of CRTH2
04/03/2012US8148541 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same
04/03/2012US8148531 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
04/03/2012US8148525 2,4-pyrimidinediamine compounds and their uses
04/03/2012US8148521 Arthropodicidal anthranilamides
04/03/2012US8148422 Sulfonamides as TRPM8 modulators
04/03/2012US8148397 5-HT7 receptor antagonists
04/03/2012US8148374 Concurrent administering of drugs; side effect reduction
04/03/2012US8148372 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286
04/03/2012US8148370 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof
04/03/2012US8148369 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
04/03/2012US8148367 Renin inhibitors
04/03/2012US8148363 Heterocyclic compounds as factor IXA inhibitors
04/03/2012CA2648157C 1-alkyl-5-aryl-3-arylamino-1h-1,2,4-triazoles as positive allosteric modulators of the alpha 7 receptor
04/03/2012CA2554187C 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines compound
04/03/2012CA2505427C Bicyclic-substituted amines as histamine-3 receptor ligands
03/2012
03/29/2012WO2012040532A1 Substituted oxadiazole compounds and their use as s1p1 agonists
03/29/2012WO2012040279A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012WO2012040258A2 Therapeutic piperazines
03/29/2012WO2012040204A2 Cytosolic fluorescent ion indicators
03/29/2012WO2012040139A1 Oxadiazole inhibitors of leukotriene production
03/29/2012WO2012040137A1 Oxadiazole inhibitors of leukotriene production
03/29/2012WO2012039371A1 Cyclopropane compound
03/29/2012WO2012039141A1 6-acylpyridin-2-one derivative and herbicide
03/29/2012WO2012038937A1 Aprepitant l-proline composition and cocrystal
03/29/2012WO2012038081A1 Substituted benzamide compounds
03/29/2012WO2011060877A3 Materials for organic light emitting devices
03/29/2012US20120077858 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
03/29/2012US20120077813 Imidazole Substituted Pyrimidines Useful in the Treatment of Glycogen Synthase Kinase-3 Related Disorders such as Alzheimer's Disease
03/29/2012US20120077812 Bicyclic compounds and use as antidiabetics
03/29/2012US20120077811 Prodrug forms of kinase inhibitors and their use in therapy
03/29/2012US20120077809 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077801 Chemical Compounds 637
03/29/2012US20120077796 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
03/29/2012US20120077794 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
03/29/2012US20120077793 Compounds for the Treatment of Metabolic Disorders
03/29/2012US20120077711 Novel Ligands and Libraries of Ligands
03/29/2012US20120076835 Hiv inhibiting pyrimidines derivatives
03/29/2012US20120076756 Novel benzimidazole derivatives
03/29/2012CA2846460A1 Aprepitant l-proline composition and cocrystal
03/29/2012CA2812449A1 Oxadiazole inhibitors of leukotriene production
03/29/2012CA2812061A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811796A1 Substituted benzamide compounds
03/28/2012EP2432780A1 Pyrimidine compound and its use in pest control
03/28/2012EP2432779A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432768A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP2118087B1 Pi 3-kinase inhibitors and methods of their use
03/28/2012CN1960969B Histamine H3 receptor agents, preparation method and therapeutic uses thereof
03/28/2012CN1882568B Pyrrol derivatives with antibacterial activity
03/28/2012CN102395584A Compounds for the treatment of metabolic disorders
03/28/2012CN102395583A Isoxazole derivatives
03/28/2012CN102395579A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
03/28/2012CN102395577A Diazepinedione derivative
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102391261A N-substituted dioxazine compound as well as preparation method and application thereof
03/28/2012CN102391260A 3-ketone-6-substituted-benzofuran compound as well as preparation method and application thereof
03/28/2012CN102391259A Nifuratel compound and preparation method thereof
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents